Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hemorrhagic Stroke: early-phase trial registry
6 of 7 indexed Hemorrhagic Stroke trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 6 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Hemorrhagic Stroke: 7 US clinical trials tracked, 6 recruiting.
Hemorrhagic Stroke is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is EMVision Medical Devices, running 1 of these trials.
Enrollment posture brief
Registry condition hemorrhagic-stroke
OPEN 6 | RECR 86% | LATE 0 | EARLY 1 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adenovirus (86% recruiting · 7 trials)
Hemorrhagic Stroke lists 6 open slots (86% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hemorrhagic Stroke on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hemorrhagic Stroke is recruiting above its size-band peers.
6 of 7 indexed trials (85.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Hemorrhagic Stroke trials is spread across many organizations.
EMVision Medical Devices accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Hemorrhagic Stroke enrolment sits around 300 participants.
Median target enrolment is 300 among the 7 trials that report a genuine target (sentinel values excluded). 2 of those (28.6%) plan for fewer than 100 participants.
-
Hemorrhagic Stroke splits between interventional and observational designs.
4 interventional and 3 observational studies make up this index (57.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Stroke Recovery Initiative - Registry for Stroke Research Studies
University of California, San Francisco
NCT03318432
Left Atrial Strain and Cryptogenic Stroke
University of Pittsburgh
NCT07224178
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
University of Chicago
NCT06094478
Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients
EMVision Medical Devices
NCT06999122
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
phenox
NCT07143019
Wireless Nerve Stimulation Device To Enhance Recovery After Stroke
Baylor Research Institute
NCT04534556
Efficacy, Safety and Tolerability of BAF312 Compared to Placebo in Patients With Intracerebral Hemorrhage (ICH).
Novartis Pharmaceuticals
NCT03338998
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hemorrhagic Stroke records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hemorrhagic Stroke trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hemorrhagic Stroke page
7 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Hemorrhagic Stroke trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- EMVision Medical Devices sponsors the most Hemorrhagic Stroke trials on record, review their full trial history before evaluating a specific study. See EMVision Medical Devices's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hemorrhagic Stroke condition card totals 7 registered trials; most-linked intervention Matching Placebo for BAF312 tablet; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.